News
-
-
-
-
-
-
PRESS RELEASE
Evotec announces significant progress in strategic protein degradation collaboration with Bristol Myers Squibb
Evotec SE announces significant progress in strategic protein degradation collaboration with Bristol Myers Squibb, expanding pipeline of molecular glue degraders for unmet medical needs. Performance-based payments totaling US$75 m -
PRESS RELEASE
Record order backlog at the end of Q1/2025 impressively underlines Vossloh's strong performance; positive outlook for 2025 confirmed
Vossloh's record order backlog in Q1/2025 highlights strong performance with orders at €339.2 million and backlog at €926.4 million. Positive 2025 outlook confirmed -
-
REGULATED PRESS RELEASE
Air Liquide Q1 2025 Revenue
-
PRESS RELEASE
Heidelberg Pharma AG: Interim Statement on the First Three Months of Financial Year 2025
Heidelberg Pharma AG reports positive results for ATAC candidates HDP-101 and HDP-102 in Q1 2025, extends cash reach through financing activities, and progresses towards market approval for TLX250-CDx